Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) is set to participate in the Piper Sandler 37th Annual Healthcare Conference, scheduled for Wednesday, December 3, 2025, at 4:30 p.m. Eastern Standard Time. The company's management team will engage in a fireside discussion, offering insights into Vicarious Surgical's innovative approach to robotics in surgery. Interested individuals can listen to the discussion via a live audio webcast, accessible through the “Events & Presentations” section of the company’s investor relations website.

Founded in 2014 and headquartered in Waltham, Massachusetts, Vicarious Surgical aims to revolutionize robotic surgery through next-generation technology that enhances efficiency, improves patient outcomes, and lowers healthcare costs. The company's proprietary human-like surgical robots offer a groundbreaking method for minimally invasive surgical procedures by virtually transporting surgeons inside patients.

Vicarious Surgical boasts a strong leadership team comprising technologists, medical device professionals, and physicians. The company has garnered investment from notable figures and organizations, including Bill Gates, Khosla Ventures, Innovation Endeavors, AME Cloud Ventures founded by Jerry Yang, Sun Hung Kai & Co. Ltd, and E15 VC led by Philip Liang.

To keep investors and the public informed about significant developments, Vicarious Surgical will utilize various communication channels, including its investor relations website, LinkedIn, and its X feed (@VicariousSurg). These channels will provide timely updates and important information that may affect investors. The company encourages stakeholders to stay engaged through its platforms, alongside announcements from SEC filings and other media. For more information, interested parties are directed to visit their website at www.vicarioussurgical.com.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) presents a compelling investment opportunity as it prepares to participate in the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025. The company’s innovative approach to robotic surgery positions it as a significant player in the healthcare technology sector, especially with its proprietary human-like surgical robots designed for minimally invasive procedures.

The upcoming conference provides an excellent platform for Vicarious Surgical to showcase its unique offerings to potential investors. The management’s fireside discussion is anticipated to cover their technological advancements, market potential, and the company's strategic direction. Investors should closely monitor this event for insights into Vicarious’ growth trajectory and management's vision for scaling operations and enhancing patient outcomes.

Vicarious Surgical has attracted substantial backing from notable figures and venture capital firms, such as Bill Gates and Khosla Ventures. This level of endorsement highlights the confidence industry veterans have in the company’s disruptive technology and long-term value. Additionally, the focus on reducing healthcare costs and improving surgical efficiency aligns with current trends in the medical field, which increasingly prioritize value-based care.

Investors should be aware of the competitive landscape as well. While Vicarious stands out with its unique surgical approach, the market is populated with established medical device manufacturers and emerging startups. Thus, keeping track of industry innovations, regulatory developments, and competitive actions will be pivotal.

Given the potential for substantial return on investment in the burgeoning field of robotic surgery, participating investors should consider Vicarious Surgical's future engagements and product developments following the conference. Staying updated through their investor relations platform and social media channels will provide valuable information to make informed investment decisions.